Novel Glutamine Antagonist JHU395 Suppresses MYC-Driven Medulloblastoma Growth and Induces ApoptosisKhoa Pham, Eric H. Raabe, Micah J. Maxwell et al.|Journal of Neuropathology & Experimental Neurology|2021Cited by 27
Comprehensive Metabolic Profiling of MYC-Amplified Medulloblastoma Tumors Reveals Key Dependencies on Amino Acid, Tricarboxylic Acid and Hexosamine PathwaysKhoa Pham, Eric H. Raabe, Akhila Parthasarathy et al.|Cancers|2022Cited by 21
MEK Inhibition Suppresses Growth of Atypical Teratoid/Rhabdoid TumorsShubin Shahab, Eric H. Raabe, Charles G. Eberhart et al.|Journal of Neuropathology & Experimental Neurology|2020Cited by 9
Unbiased Proteomic and Phosphoproteomic Analysis Identifies Response Signatures and Novel Susceptibilities After Combined MEK and mTOR Inhibition in BRAFV600E Mutant GliomaMicah J. Maxwell, Eric H. Raabe, Charles G. Eberhart et al.|Molecular & Cellular Proteomics|2021Cited by 7
OTME-9. Comprehensive Metabolic Profiling Of high MYC Medulloblastoma Reveals Key Differences Between In <i>Vitro</i> And In <i>Vivo</i> Glucose And Glutamine UsageKhoa Pham, Eric H. Raabe, Charles G. Eberhart et al.|Neuro-Oncology Advances|2021Cited by 1